NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/08/2023
Voltar para busca
Dado oficial do USPTO
LUMABRIDGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
29/08/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 42, 45
Data de depósito
19/07/2022
Data de registro
29/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/08/2023
Última transação
29/08/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/08/2022
Primeiro uso no comércio
23/08/2022
Código do desenho
3
Tipo de titular
16
Localização do titular
SAN ANTONIO, TX
Examinador
LEVINE, HOWARD
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "LumaBridge" with a pattern of radiating lines forming a semi-circle over the last 5 letters of the word portion of the mark.
Titulares e representantes
Titulares
LUMABRIDGE, LLC
Clinical Research Insight, LLC
Representantes
Megan R. Bradshaw PIRKEY BARBER PLLC
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trialsproviding information management services; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence services in the fields of medical devices and pharmaceuticals
Classe 42
Medical and scientific researchconducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the fields of oncologyimmunologymilitary medicineemergency medicinecritical careregenerative medicineinfectious disease; Consulting services for others in the field of designplanningimplementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines
Classe 45
Regulatory compliance consulting in the field of prescription drug sampling
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/08/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
25/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
24/07/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
21/06/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/06/2023
IUAF
USE AMENDMENT FILED
25/05/2023
EISU
TEAS STATEMENT OF USE RECEIVED
25/05/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
28/12/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/10/2022
PUBO
PUBLISHED FOR OPPOSITION
25/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/09/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
21/09/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/09/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
21/09/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/08/2022
GNRT
NON-FINAL ACTION E-MAILED
19/08/2022
CNRT
NON-FINAL ACTION WRITTEN
19/08/2022
DOCK
ASSIGNED TO EXAMINER
19/08/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2022
NWAP
NEW APPLICATION ENTERED
22/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LUMABRIDGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.